Lantern Pharma Inc.
LTRN$32M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaDALLAS24 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
LTRN News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply